Literature DB >> 27448630

A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1 ) in the liver.

Elizabeth M Tunnicliffe1, Rajarshi Banerjee1, Michael Pavlides1,2, Stefan Neubauer1, Matthew D Robson1.   

Abstract

PURPOSE: To propose a simple multicompartment model of the liver and use Bloch-McConnell simulations to demonstrate the effects of iron and fibrosis on shortened-MOLLI (shMOLLI) T1 measurements. Liver T1 values have shown sensitivity to inflammation and fibrosis, but are also affected by hepatic iron content. Modified Look-Locker inversion recovery (MOLLI) T1 measurements are biased by the lower T2 associated with high iron.
MATERIALS AND METHODS: A tissue model was generated consisting of liver cells and extracellular fluid (ECF), with iron-dependent relaxation rates. Fibrosis was imitated by increasing the ECF proportion. Simulations of the shMOLLI sequence produced a look-up table (LUT) of shMOLLI-T1 for a given ECF fraction and iron content. The LUT was used to calculate ECF(shMOLLI-T1 ), assuming normal hepatic iron content (HIC), and ECF(shMOLLI- T1,T2*), accounting for HIC determined by T2*, for 77 patients and compared to fibrosis assessed by liver biopsy.
RESULTS: Simulations showed that increasing HIC decreases shMOLLI-T1 , with an increase in HIC from 1.0 to 2.5 mg/g at normal ECF fraction decreasing shMOLLI-T1 by 160 msec, while increasing ECF increased ShMOLLI-T1 , with an increase of 20% ECF at normal iron increasing shMOLLI-T1 by 200 msec. Calculated patient ECF(shMOLLI-T1 ) showed a strong dependence on Ishak score (3.3 ± 0.8 %ECF/Ishak stage) and 1/T2* (-0.23 ± 0.04 %ECF/Hz). However, when iron was accounted for to produce ECF(shMOLLI- T1,T2*), it was independent of HIC but retained sensitivity to Ishak score.
CONCLUSION: Use of this multicompartment model of the liver with Bloch-McConnell simulation should enable compensation of iron effects when using shMOLLI-T1 to assess fibrosis. LEVEL OF EVIDENCE: 1 J. Magn. Reson. Imaging 2017;45:450-462.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  T1 mapping; liver MRI; liver disease

Mesh:

Substances:

Year:  2016        PMID: 27448630     DOI: 10.1002/jmri.25392

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  25 in total

1.  T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis.

Authors:  David H Hoffman; Abimbola Ayoola; Dominik Nickel; Fei Han; Hersh Chandarana; Krishna Prasad Shanbhogue
Journal:  Abdom Radiol (NY)       Date:  2020-03

2.  Magnetic resonance imaging T1 relaxation times for the liver, pancreas and spleen in healthy children at 1.5 and 3 tesla.

Authors:  Leah A Gilligan; Jonathan R Dillman; Jean A Tkach; Stavra A Xanthakos; Jacqueline K Gill; Andrew T Trout
Journal:  Pediatr Radiol       Date:  2019-05-02

3.  Association of Liver Fibrosis With Cardiovascular Diseases in the General Population: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mohammad R Ostovaneh; Bharath Ambale-Venkatesh; Tomoki Fuji; Hooman Bakhshi; Ravi Shah; Venkatesh L Murthy; Russell P Tracy; Eliseo Guallar; Colin O Wu; David A Bluemke; João A C Lima
Journal:  Circ Cardiovasc Imaging       Date:  2018-03       Impact factor: 7.792

4.  Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis.

Authors:  Michelle T Long; Emelia J Benjamin
Journal:  Circ Cardiovasc Imaging       Date:  2018-03       Impact factor: 7.792

5.  Free-breathing multitasking multi-echo MRI for whole-liver water-specific T1 , proton density fat fraction, and R 2 quantification.

Authors:  Nan Wang; Tianle Cao; Fei Han; Yibin Xie; Xiaodong Zhong; Sen Ma; Alan Kwan; Zhaoyang Fan; Hui Han; Xiaoming Bi; Mazen Noureddin; Vibhas Deshpande; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2021-08-21       Impact factor: 4.668

6.  Multiparametric Renal Magnetic Resonance Imaging: Validation, Interventions, and Alterations in Chronic Kidney Disease.

Authors:  Eleanor F Cox; Charlotte E Buchanan; Christopher R Bradley; Benjamin Prestwich; Huda Mahmoud; Maarten Taal; Nicholas M Selby; Susan T Francis
Journal:  Front Physiol       Date:  2017-09-14       Impact factor: 4.566

Review 7.  Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.

Authors:  Suraj D Serai; Andrew T Trout; Alexander Miethke; Eric Diaz; Stavra A Xanthakos; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

8.  Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.

Authors:  Michael Pavlides; Rajarshi Banerjee; Elizabeth M Tunnicliffe; Catherine Kelly; Jane Collier; Lai Mun Wang; Kenneth A Fleming; Jeremy F Cobbold; Matthew D Robson; Stefan Neubauer; Eleanor Barnes
Journal:  Liver Int       Date:  2017-05-30       Impact factor: 5.828

9.  Validation of a standardized MRI method for liver fat and T2* quantification.

Authors:  Chloe Hutton; Michael L Gyngell; Matteo Milanesi; Alexandre Bagur; Michael Brady
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

10.  Liver cT1 decreases following direct-acting antiviral therapy in patients with chronic hepatitis C virus.

Authors:  Eleanor Barnes; Michael Pavlides; Arjun N A Jayaswal; Christina Levick; Jane Collier; Elizabeth M Tunnicliffe; Matthew D Kelly; Stefan Neubauer
Journal:  Abdom Radiol (NY)       Date:  2020-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.